Profil
Martyn D.
Williams worked as the Chief Executive Officer and Executive Director at Ark Therapeutics Group Plc from 2012 to 2012.
He also worked as the Chief Financial Officer at Walsh International, Inc.
Anciens postes connus de Martyn D. Williams
| Sociétés | Poste | Fin |
|---|---|---|
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | President | 31/07/2012 |
Walsh International, Inc.
 Walsh International, Inc. Information Technology ServicesTechnology Services Part of IQVIA Holdings, Inc., Walsh International, Inc. is a company that develops marketing and sales information systems. The company is based in Newtown, PA. Walsh International was acquired by Cognizant Corp on August 31, 1998 for $184.63 million. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Walsh International, Inc.
Walsh International, Inc. Information Technology ServicesTechnology Services Part of IQVIA Holdings, Inc., Walsh International, Inc. is a company that develops marketing and sales information systems. The company is based in Newtown, PA. Walsh International was acquired by Cognizant Corp on August 31, 1998 for $184.63 million. | Technology Services |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |